Gastro-enteropancreatic neuroendocrine tumor
Other Names for this Disease
- GEP tumors
RDCRN 3rd Conference on Clinical Research for Rare Diseases, Tuesday, October 02, 2012
Location: Hilton Washington DC/Rockville Hotel & Executive Meeting Center, Rockville, MD
Description: Clinical research in rare diseases presents a number of challenges and unique issues that are not usually considered in the training of clinical investigators through existing training programs. Goals of the conference include: direct instruction of trainees and new investigators in rare disease research methodology; development of a reusable curriculum/syllabus on rare disease research methodology; and stimulation of ideas regarding the unique issues facing investigators engaged in the study of rare diseases.
Overcoming Barriers to International Clinical Trials for Rare Cancers , Friday, December 10, 2010
Location: Bethesda, Maryland
Description: The goals of this conference were to introduce key institutional players to the topic of international clinical trials in rare cancers and to establish an ongoing dialogue. Participants left the meeting with a set of specific priorities that need to be enacted to promote these trials. The meeting promoted consensus on the way that resources are prioritized to address rare cancers. Participants were asked to convey the content of the meeting to their constituencies and to follow up with pilot concepts.
VI International Conference on Rare Diseases and Orphan Drugs (ICORD 2010): Global Approach to Accessibility in Rare Diseases, Orphan Drugs and Neglected Diseases , Thursday, March 18, 2010 - Saturday, March 20, 2010
Location: Palais Rouge Convention Center, Palermo, Buenos Aires, Argentina
Description: For the first time, the VI International Conference on Rare Diseases and Orphan Drugs (ICORD 2010) was convened in the southern hemisphere in agreement with its aim of globalization of rare diseases research and orphan products development activities.
NCI Summit on Carcinoids and Neuroendocrine Tumors, Wednesday, September 12, 2007 - Thursday, September 13, 2007
Location: Rockville, MD
Description: The goals of this summit were to assess the current status of neuroendocrine tumor biology, diagnosis, and treatment and to develop a comprehensive set of recommendations that address the major barriers to early diagnosis and treatment. There are plans to submit a synopsis of this summit and the list of recommendations for publication in a cancer journal and to members of the U.S. Congress. It was anticipated that this summit would increase general awareness of this disease, stimulate scientific interest in this under-represented area, and potentially open up new avenues of funding.